55I LLC’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$333K Hold
4,669
0.01% 473
2022
Q2
$350K Sell
4,669
-1,946
-29% -$148K 0.01% 410
2022
Q1
$526K Hold
6,615
0.01% 354
2021
Q4
$537K Hold
6,615
0.01% 338
2021
Q3
$512K Hold
6,615
0.02% 315
2021
Q2
$532K Hold
6,615
0.02% 253
2021
Q1
$522K Hold
6,615
0.03% 205
2020
Q4
$472K Hold
6,615
0.04% 170
2020
Q3
$422K Hold
6,615
0.04% 191
2020
Q2
$428K Buy
6,615
+141
+2% +$8.76K 0.06% 158
2020
Q1
$381K Buy
+6,474
New +$394K 0.11% 123

Other funds holding PJP

55I LLC's PJP Position: Q3 2022 in Review

55I LLC held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2022 at 4,669 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #473.

55I LLC first reported a position in PJP in Q1 2020 and has held it in 11 quarters since. The position peaked at $537K in Q4 2021. 81 funds tracked by Wall St. Rank hold PJP as of Q3 2022.

  • 55I LLC held 4,669 shares of Invesco Pharmaceuticals ETF worth $333K as of Q3 2022.
  • 55I LLC left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2022.
  • Invesco Pharmaceuticals ETF made up 0.01% of 55I LLC's portfolio in Q3 2022, its #473 holding.
  • 55I LLC first reported a position in Invesco Pharmaceuticals ETF in Q1 2020 and has held it in 11 quarters since.
  • 55I LLC's Invesco Pharmaceuticals ETF position peaked at $537K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.